ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Berlin, BE, DEU:

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO-GREEN)

RAINBO MMRd-GREEN is an international, multicenter, phase III randomised trial wherein adjuvant pelvic external beam radiotherapy combined with and f...

Enrolling
Endometrial Cancer
Radiation: Pelvic external beam radiotherapy
Drug: Durvalumab

Phase 3

Leiden University Medical Center (LUMC)

Berlin, Germany and 59 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Rescue medications

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Berlin, Germany and 243 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 255 other locations

The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...

Enrolling
Endometrial Cancer
Drug: Doxorubicin
Drug: Docetaxel

Phase 3

BioNTech
BioNTech

Berlin, Germany and 205 other locations

Locations recently updated

standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...

Enrolling
Endometrial Cancer
Recurrent or Progressive Endometrial Cancer
Drug: Rina-S
Drug: IC

Phase 3

Genmab
Genmab

Berlin, State of Berlin, Germany and 179 other locations

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advance...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Biological: Pembrolizumab

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Berlin, Germany and 268 other locations

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer...

Enrolling
Endometrial Cancer
Ovarian Cancer
Drug: Bevacizumab
Drug: Pembrolizumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 59 other locations

Additionally, this study will test how well EIK1005 is tolerated alone and in combination with pembrolizumab in treating patients with advanced cancer...

Enrolling
Endometrial Cancer
MSI-H/dMMR Gastroesophageal-junction Cancer
Drug: pembrolizumab (KEYTRUDA® )
Drug: EIK1005

Phase 1, Phase 2

Eikon Therapeutics

Berlin, Germany and 44 other locations

global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: Bevacizumab 10 mg/kg
Drug: Nab-paclitaxel 80 mg/m^2

Phase 2

Corcept Therapeutics
Corcept Therapeutics

Berlin, Germany and 48 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Capecitabine
Drug: Cisplatin

Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 93 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems